Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8 + T-Cell Responses in Rhesus Macaques
- 2 April 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (7) , 3699-3706
- https://doi.org/10.1128/jvi.02255-09
Abstract
Here we describe a novel vaccine vector for expressing human immunodeficiency virus (HIV) antigens. We show that recombinant attenuated yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 Gag sequences can be used as a vector to generate SIV-specific CD8(+) T-cell responses in the rhesus macaque. Priming with recombinant BCG expressing SIV antigens increased the frequency of these SIV-specific CD8(+) T-cell responses after recombinant YF17D boosting. These recombinant YF17D-induced SIVspecific CD8(+) T cells secreted several cytokines, were largely effector memory T cells, and suppressed viral replication in CD4(+) T cells.This publication has 45 references indexed in Scilit:
- Effective Simian Immunodeficiency Virus-Specific CD8+T Cells Lack an Easily Detectable, Shared CharacteristicJournal of Virology, 2010
- Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous ChallengeJournal of Virology, 2009
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challengeNature Medicine, 2009
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human VolunteersThe Journal of Infectious Diseases, 2008
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialPublished by Elsevier ,2008
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeysNature, 2008
- Macaques vaccinated with live-attenuated SIV control replication of heterologous virusThe Journal of Experimental Medicine, 2008
- Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239Journal of Virology, 2006
- A live, attenuated recombinant West Nile virus vaccineProceedings of the National Academy of Sciences, 2006